Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Pot

Showing results (51-60 of 107) with videos related to

Pageof 11
Sort By:
Multiple Sclerosis and Related Disorders|July 31, 2018
The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most?Laura Barin, Anke Salmen, Giulio Disanto, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 19, 2018
Factors associated with time from first-symptoms to diagnosis and treatment initiation of Multiple Sclerosis in SwitzerlandMarco Kaufmann, Jens Kuhle, Milo A Puhan, et al.
Frontiers in Immunology|August 8, 2024
Human stem cell-derived neurons and astrocytes to detect novel auto-reactive IgG response in immune-mediated neurological diseasesAmandine Mathias, Sylvain Perriot, Samuel Jones, et al.
Medical Image Analysis|February 13, 2021
Comparison of non-parametric T<sub>2</sub> relaxometry methods for myelin water quantificationErick Jorge Canales-Rodríguez, Marco Pizzolato, Gian Franco Piredda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 3, 2009
Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cellsCaroline Pot, Hulin Jin, Amit Awasthi, et al.
Frontiers in Neurology|March 27, 2020
60/30: 60% of the Morbidity-Associated Multiple Sclerosis Disease Burden Comes From the 30% of Persons With Higher ImpairmentsMarco Kaufmann, Milo Alan Puhan, Anke Salmen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 6, 2025
Metabolic profiles of the human blood-brain barrier cells treated by TNF-alpha and oxysterolsCindy Nguyen, Kenneth C P Cheung, Xiaoli Chen, et al.
Revue Medicale Suisse|January 17, 2024
[Neurology: what's new in 2023]Beatrice Pizzarotti, Amélie Buhler-Heintze, Gilles Allali, et al.
Multiple Sclerosis and Related Disorders|December 12, 2018
Patterns of care for Multiple Sclerosis in a setting of universal care access: A cross-sectional studyLaura Barin, Marco Kaufmann, Anke Salmen, et al.
Revue Medicale Suisse|January 20, 2022
[Neurology : what's new in 2021]Alex Vicino, Gilles Allali, Julien Bally, et al.
Pageof 11

Showing results (51-60 of 107) with videos related to

Sort By:
Pageof 11
Multiple Sclerosis and Related Disorders|July 31, 2018
The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most?Laura Barin, Anke Salmen, Giulio Disanto, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 19, 2018
Factors associated with time from first-symptoms to diagnosis and treatment initiation of Multiple Sclerosis in SwitzerlandMarco Kaufmann, Jens Kuhle, Milo A Puhan, et al.
Frontiers in Immunology|August 8, 2024
Human stem cell-derived neurons and astrocytes to detect novel auto-reactive IgG response in immune-mediated neurological diseasesAmandine Mathias, Sylvain Perriot, Samuel Jones, et al.
Medical Image Analysis|February 13, 2021
Comparison of non-parametric T<sub>2</sub> relaxometry methods for myelin water quantificationErick Jorge Canales-Rodríguez, Marco Pizzolato, Gian Franco Piredda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 3, 2009
Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cellsCaroline Pot, Hulin Jin, Amit Awasthi, et al.
Frontiers in Neurology|March 27, 2020
60/30: 60% of the Morbidity-Associated Multiple Sclerosis Disease Burden Comes From the 30% of Persons With Higher ImpairmentsMarco Kaufmann, Milo Alan Puhan, Anke Salmen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 6, 2025
Metabolic profiles of the human blood-brain barrier cells treated by TNF-alpha and oxysterolsCindy Nguyen, Kenneth C P Cheung, Xiaoli Chen, et al.
Revue Medicale Suisse|January 17, 2024
[Neurology: what's new in 2023]Beatrice Pizzarotti, Amélie Buhler-Heintze, Gilles Allali, et al.
Multiple Sclerosis and Related Disorders|December 12, 2018
Patterns of care for Multiple Sclerosis in a setting of universal care access: A cross-sectional studyLaura Barin, Marco Kaufmann, Anke Salmen, et al.
Revue Medicale Suisse|January 20, 2022
[Neurology : what's new in 2021]Alex Vicino, Gilles Allali, Julien Bally, et al.
Pageof 11